BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12070715)

  • 21. An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions.
    Anichini A; Molla A; Mortarini R; Tragni G; Bersani I; Di Nicola M; Gianni AM; Pilotti S; Dunbar R; Cerundolo V; Parmiani G
    J Exp Med; 1999 Sep; 190(5):651-67. PubMed ID: 10477550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo.
    Adamus G; Machnicki M; Elerding H; Sugden B; Blocker YS; Fox DA
    J Autoimmun; 1998 Oct; 11(5):523-33. PubMed ID: 9802939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.
    Umano Y; Tsunoda T; Tanaka H; Matsuda K; Yamaue H; Tanimura H
    Br J Cancer; 2001 Apr; 84(8):1052-7. PubMed ID: 11308253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of individual specific cytotoxic T lymphocytes for two MAGE-3-derived epitopes presented by HLA-A24.
    Katsura F; Eura M; Chikamatsu K; Oiso M; Yumoto E; Ishikawa T
    Jpn J Clin Oncol; 2000 Mar; 30(3):117-21. PubMed ID: 10798537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes.
    Oiso M; Eura M; Katsura F; Takiguchi M; Sobao Y; Masuyama K; Nakashima M; Itoh K; Ishikawa T
    Int J Cancer; 1999 May; 81(3):387-94. PubMed ID: 10209953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.
    Akiyama Y; Maruyama K; Tai S; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K
    Int J Oncol; 2008 Sep; 33(3):433-41. PubMed ID: 18695871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity.
    Matsubara S; Yamaji Y; Fujita T; Kanayama T; Yamadori I; Sato M; Fujita J; Shiotani T; Takahara J
    Lung Cancer; 1996 Jun; 14(2-3):265-71. PubMed ID: 8794409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.
    Boon AC; de Mutsert G; Graus YM; Fouchier RA; Sintnicolaas K; Osterhaus AD; Rimmelzwaan GF
    J Virol; 2002 Jan; 76(2):582-90. PubMed ID: 11752149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision.
    Bazhin AV; Shifrina ON; Savchenko MS; Tikhomirova NK; Goncharskaia MA; Gorbunova VA; Senin II; Chuchalin AG; Philippov PP
    Lung Cancer; 2001 Oct; 34(1):99-104. PubMed ID: 11557119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the HLA-A24 peptide epitope within cytomegalovirus protein pp65 recognized by CMV-specific cytotoxic T lymphocytes.
    Masuoka M; Yoshimuta T; Hamada M; Okamoto M; Fumimori T; Honda J; Oizumi K; Itoh K
    Viral Immunol; 2001; 14(4):369-77. PubMed ID: 11792066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recoverin: a potent uveitogen for the induction of photoreceptor degeneration in Lewis rats.
    Adamus G; Ortega H; Witkowska D; Polans A
    Exp Eye Res; 1994 Oct; 59(4):447-55. PubMed ID: 7859820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a MAGE-1-derived HLA-A24 epitope-specific CTL line from a Japanese metastatic melanoma patient.
    Akiyama Y; Maruyama K; Tai S; Komiyama M; Iizuka A; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K
    Anticancer Res; 2009 Feb; 29(2):647-55. PubMed ID: 19331215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of an HLA-A24-restricted cytotoxic T lymphocyte epitope from human papillomavirus type-16 E6: the combined effects of bortezomib and interferon-gamma on the presentation of a cryptic epitope.
    Morishima S; Akatsuka Y; Nawa A; Kondo E; Kiyono T; Torikai H; Nakanishi T; Ito Y; Tsujimura K; Iwata K; Ito K; Kodera Y; Morishima Y; Kuzushima K; Takahashi T
    Int J Cancer; 2007 Feb; 120(3):594-604. PubMed ID: 17096336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epitope recognition of recoverin in cancer associated retinopathy: evidence for calcium-dependent conformational epitopes.
    Adamus G; Amundson D
    J Neurosci Res; 1996 Sep; 45(6):863-72. PubMed ID: 8892098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195-203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules.
    So T; Hanagiri T; Chapiro J; Colau D; Brasseur F; Yasumoto K; Boon T; Coulie PG
    Cancer Immunol Immunother; 2007 Feb; 56(2):259-69. PubMed ID: 16758204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide vaccination for patients with melanoma and other types of cancer based on pre-existing peptide-specific ctotoxic T-lymphocyte precursors in the periphery.
    Tanaka S; Harada M; Mine T; Noguchi M; Gohara R; Azuma K; Tamura M; Yamada A; Morinaga A; Nishikori M; Katagiri K; Itoh K; Yamana H; Hashimoto T
    J Immunother; 2003; 26(4):357-66. PubMed ID: 12843798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay.
    Akiyama Y; Komiyama M; Nakamura Y; Iizuka A; Oshita C; Kume A; Nogami M; Miyata H; Ashizawa T; Yoshikawa S; Kiyohara Y; Yamaguchi K
    Cancer Immunol Immunother; 2012 Dec; 61(12):2311-9. PubMed ID: 22707303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patients.
    Maeda Y; Hida N; Niiya F; Katagiri K; Harada M; Yamana H; Kamura T; Takahashi M; Sato Y; Todo S; Itoh K
    Br J Cancer; 2002 Sep; 87(7):796-804. PubMed ID: 12232766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes.
    Tahara K; Takesako K; Sette A; Celis E; Kitano S; Akiyoshi T
    Clin Cancer Res; 1999 Aug; 5(8):2236-41. PubMed ID: 10473111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of a photoreceptor protein, recoverin, as a cancer-associated retinopathy autoantigen in human lung cancer cell lines.
    Matsubara S; Yamaji Y; Sato M; Fujita J; Takahara J
    Br J Cancer; 1996 Nov; 74(9):1419-22. PubMed ID: 8912538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.